Skip to main content
NCBI home page
Infection and Immunity logoLink to Infection and Immunity
. 1982 Aug;37(2):407–412. doi: 10.1128/iai.37.2.407-412.1982

Experimental infection and immune response of guinea pigs with varicella-zoster virus.

Y Matsunaga, K Yamanishi, M Takahashi
PMCID: PMC347548  PMID: 6288560

Abstract

An immune response (fluorescent antibody to membrane antigen) was detected in guinea pigs inoculated with varicella-zoster virus (VZV) adapted to guinea pig embryonic cells, including the Oka vaccine strain, even when inoculation was by an external route, i.e., nasal or corneal. Live or UV-inactivated virus having the same virus titer before irradiation was administered to guinea pigs by the corneal route, and antibody induction was detected only with live virus. The transmission of VZV from infected guinea pigs to noninfected ones was suggested by the appearance of antibody in the serum of the latter, who were kept in the same cage. The time course of the appearance of humoral and cellular immune responses in guinea pigs was examined by the fluorescent antibody to membrane antigen test and the skin reaction, with varicella antigen representing delayed-type hypersensitivity. When VZV was injected subcutaneously, skin reaction appeared as early as 4 days after inoculation, which preceded the appearance of detectable antibody by 2 to 6 days. In in vitro studies, the Oka vaccine showed a higher adsorption rate and better growth in guinea pig embryonic cells than did other wild-type strains when assayed by the infectious center assay. These results suggest that a system of VZV adapted to guinea pig cells and guinea pigs provides a good animal experimental model for immunological study of VZV infection.

Full text

PDF
407

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Asano Y., Shiraki K., Takahashi M., Nagai H., Ozaki T., Yazaki T. Soluble skin test antigen of varicella-zoster virus prepared from the fluid of infected cultures. J Infect Dis. 1981 May;143(5):684–692. doi: 10.1093/infdis/143.5.684. [DOI] [PubMed] [Google Scholar]
  2. Asano Y., Takahashi M. Studies on neutralization of varicella-zoster virus and serological follow-up of cases of varicella and zoster. Biken J. 1978 Mar;21(1):15–23. [PubMed] [Google Scholar]
  3. Baba K., Yabuuchi H., Okuni H., Takahashi M. Studies with live varicella vaccine and inactivated skin test antigen: protective effect of the vaccine and clinical application of the skin test. Pediatrics. 1978 Apr;61(4):550–555. [PubMed] [Google Scholar]
  4. Gershon A. A. Live attenuated Varicella-Zoster vaccine. Rev Infect Dis. 1980 May-Jun;2(3):393–407. doi: 10.1093/clinids/2.3.393. [DOI] [PubMed] [Google Scholar]
  5. HEUSCHELE W. P. Varicella (chicken pox) in three young anthropoid apes. J Am Vet Med Assoc. 1960 Mar 15;136:256–257. [PubMed] [Google Scholar]
  6. Kamiya H., Ihara T., Hattori A., Iwasa T., Sakurai M., Izawa T., Yamada A., Takahashi M. Diagnostic skin test reactions with varicella virus antigen and clinical application of the test. J Infect Dis. 1977 Dec;136(6):784–788. doi: 10.1093/infdis/136.6.784. [DOI] [PubMed] [Google Scholar]
  7. Lausch R. N., Swyers J. S., Kaufman H. E. Delayed hypersensitivity to herpes simplex virus in the guinea pig. J Immunol. 1966 Jun;96(6):981–987. [PubMed] [Google Scholar]
  8. Myers M. G., Duer H. L., Hausler C. K. Experimental infection of guinea pigs with varicella-zoster virus. J Infect Dis. 1980 Sep;142(3):414–420. doi: 10.1093/infdis/142.3.414. [DOI] [PubMed] [Google Scholar]
  9. Nash A. A., Field H. J., Quartey-Papafio R. Cell-mediated immunity in herpes simplex virus-infected mice: induction, characterization and antiviral effects of delayed type hypersensitivity. J Gen Virol. 1980 Jun;48(Pt 2):351–357. doi: 10.1099/0022-1317-48-2-351. [DOI] [PubMed] [Google Scholar]
  10. Rogers H. W., Scott L. V., Patnode R. A. Sensitization of guinea pigs to herpes simplex virus. J Immunol. 1972 Oct;109(4):801–807. [PubMed] [Google Scholar]
  11. Takahashi M., Okuno Y., Otsuka T., Osame J., Takamizawa A. Development of a live attenuated varicella vaccine. Biken J. 1975 Mar;18(1):25–33. [PubMed] [Google Scholar]
  12. Takahashi M., Otsuka T., Okuno Y., Asano Y., Yazaki T. Live vaccine used to prevent the spread of varicella in children in hospital. Lancet. 1974 Nov 30;2(7892):1288–1290. doi: 10.1016/s0140-6736(74)90144-5. [DOI] [PubMed] [Google Scholar]
  13. Williams V., Gershon A., Brunell P. A. Serologic response to varicella-zoster membrane antigens measured by direct immunofluorescence. J Infect Dis. 1974 Dec;130(6):669–672. doi: 10.1093/infdis/130.6.669. [DOI] [PubMed] [Google Scholar]
  14. Yamanishi K., Matsunaga Y., Ogino T., Takahashi M., Takamizawa A. Virus replication and localization of varicella-zoster virus antigens in human embryonic fibroblast cells infected with cell-free virus. Infect Immun. 1980 May;28(2):536–541. doi: 10.1128/iai.28.2.536-541.1980. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Yamanishi K., Matsunaga Y., Otsuka T., Takahashi M. Immune response of guinea pigs to varicella vaccine strain (OKA) and wild strains. Biken J. 1980 Mar;23(1):53–55. [PubMed] [Google Scholar]

Articles from Infection and Immunity are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES